Bharat Biotech dossier under review for Covaxin emergency use listing: WHO

Credit: IndiaTimes- Published on July 19, 2021

You are here

💡 newsR Knowledge: Other News Mentions

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
Credit: IndiaTimes - Published 6 hours ago

SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
Credit: DNA - Published 4 days ago


Vaccine against COVID-19
India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..
Credit: DNA - Published 6 days ago

Related videos from verified sources

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News 02:09
Credit: Oneindia - Published on July 1, 2021 

You might like